Organogenesis Holdings (ORGO) EBIAT: 2017-2025
Historic EBIAT for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $21.6 million.
- Organogenesis Holdings' EBIAT rose 74.90% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 113.62%. This contributed to the annual value of $861,000 for FY2024, which is 82.59% down from last year.
- Latest data reveals that Organogenesis Holdings reported EBIAT of $21.6 million as of Q3 2025, which was up 329.63% from -$9.4 million recorded in Q2 2025.
- Organogenesis Holdings' EBIAT's 5-year high stood at $51.0 million during Q4 2021, with a 5-year trough of -$18.8 million in Q1 2025.
- Moreover, its 3-year median value for EBIAT was -$568,000 (2023), whereas its average is -$78,273.
- In the last 5 years, Organogenesis Holdings' EBIAT skyrocketed by 1,450.88% in 2024 and then crashed by 797.29% in 2025.
- Over the past 5 years, Organogenesis Holdings' EBIAT (Quarterly) stood at $51.0 million in 2021, then slumped by 85.32% to $7.5 million in 2022, then plummeted by 107.59% to -$568,000 in 2023, then skyrocketed by 1,450.88% to $7.7 million in 2024, then spiked by 74.90% to $21.6 million in 2025.
- Its EBIAT stands at $21.6 million for Q3 2025, versus -$9.4 million for Q2 2025 and -$18.8 million for Q1 2025.